N.J. Admin. Code § 8:51A-1.3

Current through Register Vol. 56, No. 11, June 3, 2024
Section 8:51A-1.3 - Definitions

The following words and terms, when used in this chapter, shall have the following meanings, unless the context clearly indicates otherwise.

"Anticipatory guidance" means the provision of information regarding the major causes of elevated blood lead levels and the means of preventing lead exposure to parents or guardians of children less than 72 months of age.

"CLIA" means the New Jersey Clinical Laboratory Improvement Act, found at N.J.S.A. 45:9-42.26et seq.

"Commissioner" means the Commissioner of the New Jersey Department of Health.

"Confirmed elevated blood lead" means a blood lead test result on a venous blood sample equal to or greater than five micrograms per deciliter (g/dL) of whole blood.

"Currently accepted medical guidelines" means that version of guidelines for the medical treatment of children with elevated blood lead levels most recent to the time of evaluation, treatment, and follow-up, published by a public health agency other than the Department, or recognized medical professional organization or agency, including the United States Centers for Disease Control and Prevention, the New Jersey Physicians Lead Advisory Committee, and the American Academy of Pediatrics.

"Department" means the New Jersey Department of Health.

"Elevated blood lead" means a blood lead test result, from either a venous or capillary sample, equal to or greater than five micrograms per deciliter (g/dL) of whole blood.

"Environmental follow-up" means actions taken by a local health department to identify and remediate lead hazards in the environment of a child with elevated blood lead in accordance with Chapter XIII of the New Jersey State Sanitary Code, N.J.A.C. 8:51, as amended and supplemented.

"Health care facility" means a facility licensed to perform health care services pursuant to 26:2H-1 et seq., as amended and supplemented.

"Lead screening" means the taking of a blood sample from a person by either fingerstick (capillary blood) or venipuncture (venous blood) and its analysis by a licensed clinical laboratory to determine the person's blood lead level.

"Micrograms per deciliter" or "g/dL" means a unit of measure to express the ratio of millionths of a gram of lead in one-tenth of a liter of whole blood.

"Registered professional nurse, as appropriate" means a registered nurse, licensed by the New Jersey Board of Nursing, who would be permitted to perform lead screening on his or her own authority as authorized by the Board of Nursing.

N.J. Admin. Code § 8:51A-1.3

Amended by 49 N.J.R. 3219(a), effective 9/18/2017
Amended by 51 N.J.R. 83(a), effective 1/7/2019